Market Overview

UPDATE: Morgan Stanley Upgrades Becton Dickinson to Equal-Weight on Margin, Organic Growth

Related BDX
World Health Organization Issues Prequalification Of BD FACSPresto Near-Patient CD4 Counter System For HIV/AIDS Monitoring
Death Cross Stocks - The Coca-Cola Company, Crocs, Inc. & More

Morgan Stanley raised its rating on Becton Dickinson (NYSE: BDX) from Underweight to Equal-weight and removed its price target of $68.

Morgan Stanley commented, "Upgrading BD to Equal-weight from Underweight. Organic growth and leverage are poised for a positive inflection after a two-year investment cycle. We are comfortable with valuation following 12% underperformance in 2012. To move to Overweight, we'd need better visibility on pipeline execution."

Becton Dickinson closed at $79.45 on Wednesday.

Latest Ratings for BDX

DateFirmActionFromTo
Aug 2014BarclaysMaintainsUnderweight
Aug 2014JP MorganMaintainsUnderweight
Jun 2014BarclaysMaintainsUnderweight

View More Analyst Ratings for BDX
View the Latest Analyst Ratings

Posted-In: Morgan StanleyAnalyst Color Upgrades Pre-Market Outlook Analyst Ratings

 

Related Articles (BDX)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters